Peptide stability determines the window of usable research material. Degradation mechanisms, storage conditions, and handling practices collectively dictate shelf life and bioactivity retention.
Peptide bonds undergo hydrolytic cleavage, particularly at elevated temperatures and extreme pH.
| Bond Type | Susceptibility | Conditions |
|---|
| Asp-Pro | Very high | Mild acid, neutral pH |
| Asp-Gly | High | Acidic conditions |
| Asn-Gly | High | Alkaline pH |
| General peptide bonds | Moderate | pH <3 or pH >9 |
Kinetics: Hydrolysis rate doubles for every 10°C increase (Arrhenius relationship).
Methionine and cysteine residues are primary oxidation targets:
| Residue | Product | Consequence |
|---|
| Methionine | Methionine sulfoxide | Altered hydrophobicity, reduced activity |
| Cysteine | Cysteic acid | Disulfide bond disruption |
| Tryptophan | Oxindolylalanine | Fluorescence loss, aggregation |
| Histidine | 2-oxo-histidine | Cross-linking, aggregation |
Mitigation: Nitrogen overlay, antioxidant excipients, amber vials.
Peptides form aggregates through multiple pathways:
| Pathway | Trigger | Prevention |
|---|
| Hydrophobic interaction | Concentration, temperature | Dilution, cold storage |
| Disulfide scrambling | Cysteine oxidation | Inert atmosphere |
| Secondary structure formation | pH, ionic strength | Buffer optimization |
| Surface adsorption | Container material | Low-binding surfaces |
Asparagine and glutamine residues undergo deamidation:
| Residue | Product | pH Dependence |
|---|
| Asn | Asp + isoAsp | Faster at pH 4–6 |
| Gln | Glu | Slower, pH-dependent |
Significance: Alters charge, structure, and potentially bioactivity.
| Condition | Shelf Life | Notes |
|---|
| 2–8°C | 12–24 months | Standard storage |
| −20°C | 24–60 months | Extended storage |
| −80°C | 60+ months | Long-term archival |
| Room temperature | Days–weeks | Short-term only |
| Condition | Shelf Life | Notes |
|---|
| 2–8°C | 14–30 days | Standard |
| Room temperature | 24 hours | Use same day |
| −20°C | Not recommended | Freeze-thaw damage |
Each freeze-thaw cycle causes:
- Ice crystal formation → physical stress on peptide structure
- Concentration effects → local supersaturation during freezing
- Surface adsorption → peptide loss to container walls
- pH shifts → buffer component precipitation
Best practice: Aliquot into single-use volumes before freezing.
| Factor | Impact | Mitigation |
|---|
| Accelerated degradation | Arrhenius kinetics | Cold storage |
| Conformational changes | Thermal denaturation | Controlled temperature |
| Aggregation | Hydrophobic exposure | Low temperature |
| Microbial growth | Contamination | Refrigeration |
| Peptide Type | Optimal pH | Stability Window |
|---|
| Most peptides | 4–7 | pH 3–8 |
| Acid-stable peptides | 2–5 | pH 1–6 |
| Base-stable peptides | 8–10 | pH 7–11 |
| Amino Acid | Light Sensitivity | Protection |
|---|
| Tryptophan | High | Amber vials |
| Tyrosine | Moderate | Dark storage |
| Phenylalanine | Low | Standard storage |
| Cysteine | Moderate | Amber vials |
- Hygroscopic lyophilized peptides absorb moisture
- Moisture accelerates hydrolysis and aggregation
- Store in desiccated environment
- Use desiccant packs for lyophilized storage
| Parameter | Acceptable | Reject |
|---|
| Clarity | Clear | Turbid, cloudy |
| Color | Colorless (or specified) | Yellow, brown, pink |
| Particles | None | Any visible particles |
| Precipitate | None | Any sediment |
| Method | Application | Detection |
|---|
| HPLC (RP) | Purity, degradation products | UV 210–220 nm |
| HPLC (SEC) | Aggregation | UV 210–220 nm |
| IEX-HPLC | Charge variants | UV 210–220 nm |
| CE | Purity, charge variants | UV 214 nm |
| Method | Application |
|---|
| MALDI-TOF | Molecular weight verification |
| ESI-MS | Intact mass, modifications |
| LC-MS/MS | Peptide mapping, modification ID |
| Assay Type | Application |
|---|
| Cell-based potency | Functional activity |
| Receptor binding | Affinity retention |
| In vivo efficacy | Biological effect |
| Peptide | Lyophilized Shelf Life | Reconstituted Shelf Life | Key Concern |
|---|
| Semaglutide | 36 months | 30 days at 2–8°C | Aggregation |
| Liraglutide | 24 months | 30 days at 2–8°C | Deamidation |
| Exenatide | 24 months | Use same day | Hydrolysis |
| Peptide | Lyophilized Shelf Life | Reconstituted Shelf Life | Key Concern |
|---|
| Somatropin | 24 months | 14–28 days at 2–8°C | Aggregation |
| Sermorelin | 24 months | 48 hours | Hydrolysis |
| CJC-1295 | 24 months | 30 days at 2–8°C | Oxidation |
| Peptide | Lyophilized Shelf Life | Reconstituted Shelf Life | Key Concern |
|---|
| BPC-157 | 24 months | 30 days at 2–8°C | Minimal (very stable) |
| TB-500 | 24 months | 30 days at 2–8°C | Aggregation |
| GHK-Cu | 24 months | 30 days at 2–8°C | Copper complexation |
- Allow vials to reach room temperature before opening
- Use aseptic technique for all reconstitutions
- Minimize time at room temperature
- Avoid repeated freeze-thaw cycles
- Use low-protein-binding tubes and tips
- Record storage conditions from receipt
- Log reconstitution date and time
- Document any visual changes
- Track freeze-thaw cycles
- Note expiration dates
- Visual inspection before each use
- HPLC purity check for critical applications
- Potency assay for bioactive peptides
- Molecular weight verification for new lots
- USP. “United States Pharmacopeia General Chapter <1191> Stability Testing of Peptide and Protein Drug Products.” USP 2023.
- ICH. “Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products.” ICH Q5C 2023.